Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder

Nordic Journal of Psychiatry

Volumn 62, Issue 6, 2008, Pages 496-502

  Kim, Jeong Hyun ^a,b   Choi, Sung Won ^a,b   Joe, Soo Hyun ^a,b   Ha, Tae Hyon ^a,b   Yoo, Hee Jeong ^a,b   Choi, Jung Eun ^a,b   Cha, Boseok ^a,b   Ha, Kyooseob ^a,b  

^a Seoul National University   (South Korea)

^b Bugok National Hospital   (South Korea)

Author keywords

Bipolar disorder; Reliability; Self report; Side effects; Validity

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CLOZAPINE; FLUOXETINE; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SERTRALINE; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE;

ADULT; AKATHISIA; AKINESIA; AMENORRHEA; ARTICLE; ASTHENIA; BIPOLAR DISORDER; COGNITIVE DEFECT; CONCURRENT VALIDITY; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DIZZINESS; DRUG ERUPTION; DYSKINESIA; DYSTONIA; EJACULATION DISORDER; EMOTIONAL DISORDER; EPILEPSY; ERECTILE DYSFUNCTION; EXCESSIVE DREAMING; FEMALE; GALACTORRHEA; GYNECOMASTIA; HAMILTON SCALE; HEADACHE; HEART PALPITATION; HUMAN; HYPERKINESIA; HYPOKINESIA; KOREA; LASSITUDE; LIBIDO; MAJOR CLINICAL STUDY; MALE; MANIA; MEMORY DISORDER; MENORRHAGIA; MENTAL PATIENT; MICTURITION DISORDER; MUSCLE RIGIDITY; NAUSEA; ORGASM DISORDER; PARESTHESIA; PHOTOSENSITIVITY; PIGMENT DISORDER; POLYDIPSIA; POLYURIA; PRURITUS; RATING SCALE; RELIABILITY; SALIVATION DISORDER; SELF REPORT; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; SWEATING; TACHYCARDIA; TEST RETEST RELIABILITY; TREMOR; UDVALG FOR KLINISKE UNDERSOGELSER SIDE EFFECTS RATING SCALE FOR PATIENTS; VALIDITY; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KOREA; LITHIUM CARBONATE; MALE; MIDDLE AGED; OBSERVER VARIATION; PATIENT COMPLIANCE; PATIENT SATISFACTION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTROPIC DRUGS; REPRODUCIBILITY OF RESULTS; VALPROIC ACID;

EID: 57049127531     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.1080/08039480801985229     Document Type: Article

References (26)

1. Day, JC, Wood, G., Dewy, M. and Bentall, RP. (1995) A self-rating scale for measuring neuroleptic side effects: Validation in a group of schizophrenic patients. Br J Psychiatry, 166, pp. 650-653.
2. Lader, M. and Lewander, T. (1994) The neuroleptic-induced deficit syndrome. Acta Psychiatr Scand, 89, pp. 1-85.
3. Kane, JM. (1994) Dosage and route of administration of neuroleptic drugs during different phases of schizophrenia illness. Guidelines for neuroleptic relapse prevention in schizophrenia, pp. 85-93. Springer, Berlin
4. Frye, MA, Ketter, TA, Leverich, GS, Huggins, T., Lantz, C. Denicoff, KD et al. (2000) The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry, 61, pp. 9-15.
5. Wolfsperger, M., Greil, W., Rossler, W. and Grohmann, R. (2007) Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. J Affect Disord, 99, pp. 9-17.
6. Kreyenbuhl, JA, Valenstein, M., McCarthy, JF, Gancozy, D. and Blow, FC. (2007) Long-term antipsychotic polypharmacy in the VA health system: Patient characteristics and treatment patterns. Psychiatr Serv, 58, pp. 489-495.
7. Lingjaerde, O., Ahlfors, UG, Bech, P., Dencker, SJ and Elgen, K. (1987) The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand, 76, pp. 1-100.
8. van Putten, T. and May, PRA. (1978) Akinetic depression in schizophrenia. Arch Gen Psychiatry, 35, pp. 1101-1107.
9. Hogan, TP, Awad, AG and Eastwood, R. (1983) A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychol Med, 13, pp. 177-183.
10. Naber, D. (1995) A self-rating scale to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol, 10, pp. 133-138.
11. Lindstrom, E., Lewander, T., Malm, U., Malt, UF, Lublin, H. and Ahlfors, UG. (2001) Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia: Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat). Nord J Psychiatry, 55, pp. 5-69.
12. Sachs, GS. (1996) Bipolar mood disorder: Practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol, 16, pp. 32-47.
13. Goodwin, G. and Vieta, E. (2005) Effective treatment-Breaking the cycle of bipolar disorder. Eur Psychiatry, 20, pp. 365-371.
14. Post, RM, Denicoff, KD, Leverich, GS, Altshuler, LL, Frye, MA Suppes, TM et al. (2003) Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry, 64, pp. 680-690.
15. Yi, JS, Bae, SO, Ahn, YM, Park, DB, Noh, KS Shin, HK et al. (2005) Validity and reliability of the Korean version of Hamilton Depression Rating Scale (K-HDRS). J Korean Neuropsychiatr Assoc, 44, pp. 456-465.
16. Jung, HY, Cho, HS, Joo, YH, Shin, HK, Yi, JS Hwang, S. et al. (2003) A validation study of the Korean version of the Young Mania Rating Scale. J Korean Neuropsychiatr Assoc, 42, pp. 263-269.
17. Lambert, TJR, Cock, N., Alcock, SJ and Kelly, DL (2003) Conley RR. Measurement of antipsychotic-induced side effects: Support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement. Hum Psychopharmacol Clin Exp, 18, pp. 405-411.
18. Williams, VS, Baldwin, DS, Hogue, SL, Fehnel, SE, Hollis, KA Edin, HM et al. (2006) Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in two European countries: A cross-sectional patient survey. J Clin Psychiatry, 67, pp. 204-210.
19. Weiden, JP and Miller, LA. (2001) Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications. J Psychiatr Pract, 7, pp. 41-47.
20. Motejo-Gonzalez, AL, Liorca, G. and Izquierdo, JA. (1997) SSRI induced sexual dysfunction: Fluoxetine, paroxetine, sertraline and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther, 23, pp. 176-194.
21. Bond, WA and Hussar, DA. (1991) Detection methods and strategies for improving medication compliance. Austr J Hosp Psychiatry, 48, pp. 1978-1988.
22. Colom, F. and Vieta, E. (2002) Treatment adherence in bipolar patients. Clin Approach Bipolar Disord, 1, pp. 49-56.
23. Suppes, T., Baldessarini, RJ, Faedda, GL and Tohen, M. (1991) Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry, 48, pp. 1082-1088.
24. Adams, S. and Howe, J. (1993) Predicting medication compliance in a psychotic population. J Nerv Ment Dis, 181, pp. 558-560.
25. Buchanan, A. (1992) A two-year prospective study of treatment compliance in patients with schizophrenia. Psychol Med, 22, pp. 585-597.
26. Dott, SG, Weiden, P., Hopwood, P., Awad, AG, Hellewell, JS Knesevich, J. et al. (2001) An innovative approach to clinical communication in schizophrenia: The Approaches to Schizophrenia Communication (ASC) checklists. CNS Spectr, 6, pp. 333-338.